EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
01 1EUROAPI FRANCE
02 1Dasami Lab Private Limited
03 1Galenova Inc
04 1Gedeon Richter Plc.
05 1LETCO MEDICAL, LLC
06 1Medisca Inc.
07 1Pharma Source Direct, Inc.
08 1Piramal Healthcare UK Limited
09 1Professional Compounding Centers of America dba PCCA
10 1Spectrum Laboratory Products, Inc.
11 1Tianjin Jinjin Pharmaceutical Co.,Ltd
12 1Tianjin Tianyao Pharmaceuticals Co., Ltd.
13 1Zhejiang Langhua Pharmaceutical Co. Ltd.
14 1Zhejiang Shenzhou Pharmaceutical Co., Ltd.
01 3SPIRONOLACTONE
02 10Spironolactone
03 1Spironolactone Micronized
01 1Canada
02 4China
03 1France
04 1Hungary
05 2India
06 4U.S.A
07 1United Kingdom
NDC Package Code : 82298-121
Start Marketing Date : 2011-02-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 45541-1134
Start Marketing Date : 2000-02-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0096
Start Marketing Date : 2014-07-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-1377
Start Marketing Date : 2013-06-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 24584-1119
Start Marketing Date : 2013-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 49452-7220
Start Marketing Date : 1991-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61907-031
Start Marketing Date : 2016-07-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57582-030
Start Marketing Date : 2014-05-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 55525-0002
Start Marketing Date : 2018-07-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 16637-0020
Start Marketing Date : 2009-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Spironolactone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Spironolactone, including repackagers and relabelers. The FDA regulates Spironolactone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Spironolactone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Spironolactone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Spironolactone supplier is an individual or a company that provides Spironolactone active pharmaceutical ingredient (API) or Spironolactone finished formulations upon request. The Spironolactone suppliers may include Spironolactone API manufacturers, exporters, distributors and traders.
click here to find a list of Spironolactone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Spironolactone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Spironolactone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Spironolactone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Spironolactone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Spironolactone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Spironolactone suppliers with NDC on PharmaCompass.
We have 14 companies offering Spironolactone
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?